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Abstract 
 
The price of drugs in Indonesia is still relatively expensive in both the government and private sectors. A 
survey conducted in 2004 showed that the price of patented drugs in Indonesia is 22 to 26 times higher 
than the International Reference Price (IRP). As for generic drugs, though cheaper than patented drugs, 
the price is still nine times higher than the IRP. To overcome these problems, the government facilitated 
the procurement of generic drugs by using the e-Catalog. But not all hospitals can purchases drugs 
through the e-Catalog, some still use the conventional methods to supply the needs of medicine where the 
prices are more expensive than the prices of the e-Catalog. The case studies carry out in one of private 
hospital, and selection of items examined using Kraljic Portfolio Matrix. After doing research, the 
selected item that is on strategic items is Omeprazole. The price difference is due to different contract 
system. In the conventional way, the contract made between the Hospital and the main distributor. While,  
the e-Catalog way, contracts made directly to the pharmaceutical factory through the framework contract 
with government (LKPP). In the future, the conventional way must be abandoned, because through the e-
Catalog, procurement is more efficient, thereby reducing time and costs. 
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Introduction 
The largest cost component in healthcare is 
medicines that can reach up to 70% of the total 
healthcare cost. Therefore, in choosing medicines, the 
price factor must be considered whether it is 
affordable in relation to its benefits (Depkes in 
Situmorang, 2011). The price of medicines can 
influence the health level of the people, the people can 
have the chance to get better healthcare if the price of 
the medicines is affordable. As a developing country, 
the price of medicines in Indonesia is still classified as 
expensive in the government as well as the private 
sectors. A survey conducted in 2004 shows that the 
price of medicines in Indonesia is still high. For 
patented medicines in Indonesia, their prices are 22 to 
26 times higher than the International Reference Price 
(IRP).  As for generic medicines, while their prices are 
still cheaper than patented medicines, they are still 
nine times the IRP (Anggriandi et al, 2014). To solve 
this problem, today, the government facilitates the 
procurement of generic medicines using e-Catalog 
system. Generic Medicines e-Catalog System is an 
electronic information system that contains 
information regarding the medicine names, types, 
technical  specifications,  smallest  unit  prices,  and  
 
provider factories. The price listed in e-Catalog is the 
smallest unit price which already includes the tax and 
distribution cost.  However, not every hospital can 
afford the purchase of medicines using e-Catalog 
facility, as some hospitals still use the conventional 
way to fulfill the needs of medicines so there is a 
difference between the purchase price using the 
conventional way and those that use the e-Catalog 
system.  
 Table 1 shows the comparison between prices of 
medicines purchased from hospitals with regular 
procurement and e-Catalog prices. Using the 
purchasing method used by regular procurement make 
prices of medicines purchased more expensive than e-
Catalog prices. For example. the medicine type 
Glimepiride 4 mg whose purchasing price is three 
times the price listed in e-Catalog 
 
Tabel 1 Purchase Price Comparison 
 
Items 
Reguler 
Procurement 
e-Catalog 
Seftriaxoneserbukinjeksi 1 g/ 
vial 
Rp 5,000 Rp 3,300 
Ondansetroninj 4mg/ 2ml Rp 3,600 Rp 2,400 
Irbesartan300 mg Rp 3,200 Rp 2,470 
Glimepiride 4 mg Rp 1,303 Rp 430 
Omeprazoleinj 40 mg/10 ml Rp 40,000 Rp 36,000 
------------------------------------------------------------- 
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To answer these differences, this study proposed to 
analyze the structure of the supply chain both the 
procurement system. 
 
Literature Review 
According to Ballou (2004), supply chain chain 
refers to all activities related to the transformation and 
flow of goods and services, including the flow of 
information, from sources of raw materials to the end 
user. 
 In the healthcare industry, the supply chain 
related to pharmaceutical products is very important in 
ensuring high standards of care for patients and 
provide medical supplies and medical material 
sufficient consumables for pharmacies. In terms of 
costs , it is estimated that the cost of the supplies 25-
30 percent of the cost of hospital operations (Mustaffa 
& Potter, 2009). Therefore, it is important to managed 
effectively to ensure service and cost objectives are 
met . 
 This study used Kraljic Portofolio Model to 
maximize supply security and reduce costs, by making 
the most of their purchasing power. In doing so, 
procurement moves from being a transactional activity 
to a strategic activity (Kraljic,1983). Start by 
classifying all of the commodities, components, 
products, and services according to the supply risk and 
potential profit impact of each.  
Supply risk is high when the item is a scarce raw 
material, when its availability could be affected by 
government instability or natural disasters, when 
delivery logistics are difficult and could easily be 
disrupted, or when there are few suppliers. Profit 
impact is high when the item adds significant value to 
the organization's output.  
 To analyze the structure of the supply chain of 
disposable medical devices, this studi used 
pharmaceutical supply chain conducted by Mustamu 
(2007). He stated  that distribution chain of 
pharmaceutical consisted of raw material, factory, 
wholesalers, subdistributor, retailers and consumen. 
 
Research Model 
Supply Chain 
 Supply chain is a network of facilities and 
distribution options that carry out the functions of 
procurement of raw materials into semi-finished goods 
and finished goods , and distribution of finished goods 
to customers (Ganeshan & Horison in Hugos, 2003, 
3). A supply chain includes all the parts involved 
either directly or indirectly, in the process of fulfilling 
customer demand. 
 
Supply Risk and Profit Impact 
Supply chain risk can formally be defined as the 
potential loss resulting from a variation in an expected 
supply chain outcome.  
Seifbarghy (2009) stated that supply risk are all 
factors in the supply procurement items that quality or 
quantity affect the size of the risk in the company's 
supply. They are number of existing supplier, number 
of potential supplier, political risk, availability to 
supplier, lead time, financial condition, quality and 
technology level.  While Knight, Tu dan Preston 
(2014) stated that supply risk are supply scarcity and 
logistic cost. While profit impact are all factors that 
affect the profits of the company included purchased 
volume and impact on business growth. They are 
purchased volume and impact on business growth 
(Knight, Tu dan Preston, 2014); impact on 
profitability and importance of purchase (Padhi, 
Wagner and Anggarwal, 2012). 
 The analysis model in this study is based on a 
model research by Mustamu (2007). The purpose of 
this study is to shorten the supply chain of medical 
consumables material to make it more efficient.  
 
 
 
 
 
 
 
 
Figure 1. Supply Chain of Pharmaceutical 
 
By direct observation, interviews and discussions with 
the parties directly involved,  the conventional drug 
supply chain in Indonesia are described by Figure 2 as 
follows : 
 
 
 
 
 
 
 
 
Figure 2. Conventional Drug Supply Chain 
 
Based on observation, there are any differences of 
distribution structure between conventional drug 
supply chain and e-catalog drug supply chain. Figure 
3 describes e-catalog drug supply chain as follows : 
 
 
 
 
 
 
 
Figure 3. E-Catalog Drug Supply Chain 
 
This research focused to analyse the supply chain’s 
process flow on both the procurement system. The 
result is to find value in each plot and shorten the flow 
of the supply chain to be more efficient. 
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Research Method 
 This study was conducted by direct observation 
on the object of research, as well as interviews and 
discussions with the parties involved directly.  The 
aim of observation is to select of the main medical 
consumables such as seftriaxone serbuk injeksi 1 g/ 
vial, ondansetron inj 4mg/ 2ml, irbesartan 300 mg, 
glimepiride 4 mg and omeprasole inj 40mg/10 ml 
applied at Puri Asih Hospital.  
 The main medical consumables (seftriaxone 
injection 1 g/ vial, ondansetron inj 4mg/ 2ml, 
irbesartan 300 mg, glimepiride 4 mg and omeprasole 
inj 40mg/10 ml) are selected based on the 
consideration of the item cost ratio compared with the 
overall cost of purchase within one year. 
 The next stage is to use the model portfolio's 
matrix Kraljick to classifies the products based on two 
dimensions, profit impact and supply risk ('low' and 
'high'). The result is a 2x2 matrix and classified into 
four categories, namely bottleneck, non-critical, 
leverage and strategic items. 
 The following are the criteria that influence 
whether there is a risk that occurred in the 
procurement process . Where these criteria are divided 
into two dimensions, namely profit impact and supply 
risk. Supply risks are : (1) number of existing supplier, 
(2) political risk, (3) availability to supplier, (4) lead 
time, (5) financial condition, (6) quality, (7) 
technology level, (8) competitive demand, (9) storage 
possibility, (10) possibility of replacement, (11) 
quantitative flexibility, (12) qualitative flexibility, (13) 
exclusiveness, (14) supply scarcity, and (15) logistic 
cost.  Meanwhile, profit impact are : (1) purchased 
volume, (2) impact on business growth, (3) impact on 
profitability and (4) importance of purchase  
 Produc items included in the category of 
strategic goods, will be analyzed on the structure of 
the supply chain to see the added value that occurs 
along the supply chain. Then, this study will compare 
the supply chain cost structure of conventional 
procurement system and e-catalog procurement 
system. 
 
Results And Discussion 
Based on Padhi, Wagner and Aggarwal (2012), 
the Kraljic Portfolio Matrix approach consist of the 
following steps: 
Step 1: Design a linguistic scale for collecting 
importance and performance scores on the chosen 
attributes, and assign a Triangular Fuzzy Number to 
each point in the linguistic scale. 
Step 2: Collect scores of domain-experts on the 
attributes and convert into fuzzy number. In this 
research we use 10-point linguistic scale (Table 2). 
Step 3:  Compute the average of the attribute 
importance scores. To compute the average preference 
score for each attribute use formula as follows:  
m=  , m = 1, 2, .. M ……………..(2) 
 
 
where e is the index for the expert, where e=1, 2,…, E 
(here E=3) and m is the index for the purchasing 
portfolio attribute, where m=1, 2, …, M (here M=16 
for supply risk and 4 for proﬁt impact attributes). 
We denote the vector of average preference scores 
as AGSR and AGPI for supply risk and profit impact 
attributes. 
AGSR=  
AGPI=  
Step 4: Obtain the normalized supply risk and proﬁt 
impact importance scores of the attributes by 
following Steps 4a through 4c. 
Step 4a: Carry out a pair-wise comparison of the 
average importance scores to construct a fuzzy 
judgment matrix AG’: 
 
 
AG is an (MxM) matrix. The ratio-based approach is 
followed to make the pair-wise comparisons. The 
fuzzy weight vectors are given by : 
=  ; =  ; ….. =  ; =  (3) 
 
Step 4b: Use Deng’s (1999) approach to determine the 
fuzzy attribute weights (βm) from the elements of AG’ 
as 
  
…………………………………(4) 
 
Step 4c: Defuzzify the fuzzy attribute weights using  
centroid method: 
M =   ………………… (5) 
 
for all m= 1, 2, y, M, and calculate NWm, the 
normalized weight of the mth attribute, by dividing 
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the priority weight of the mth attribute by the sum of 
the priority weights m: 
 ………………(6) 
 
Step 5: Obtain performance scores from domain-
experts on the commodities under consideration, and 
calculate the average performance scores. 
Performance of a procurement system (raw material) 
can be considered a utility value and can be evaluated 
by multiplying the weight normalized (NWm) for each 
attribute by averaging the average achievement score 
((1/E) ) and summing all the attributes for 
each item purchases (of raw materials), by the formula 
j= 1,2,….,J……(7) 
 
Step 6: Positioning item with Multidimensional scale 
(MDS). MDS is used to find the dimensions and the 
pattern of dots within the most appropriate structure 
from the data. For this case the two axis of MDS is a 
supply risk and profit impact. For the n-dimensional 
Euclidean distance formula can be expressed as 
follows: 
 ……………………….. (8) 
 
Where and shows the utility score of each item 
purchases (of raw materials) j and k respectively, i = 
1,2, ..., n. In this case n = 2 (supply risk and profit 
impact). The Euclidean distance is shown in table 3. 
Figure 4 shows that this model groups ingredient 
items inside four quadrants including strategic, 
bottleneck, leverage, and non-critical quadrants. Those 
four quadrants each have different characteristics 
according to the supply risk and price impact (low and 
high) values. The position of where the medicines are 
in strategic quadrant is Omeprazole, in bottleneck is 
Seftriaxone, in leverage are Ondansetron and 
Irbesartan, and in non-critical is Glimepiride. 
Omeprazole conventional procurement system is 
shown by the following picture : 
 
Table 2. Triangular Fuzzy Number 
 
Linguistic 
Scale Point 
Triangular Fuzzy 
Number (TFN) 
None {1,1,2} 
Extremely low {1,2,3} 
Very low {2,3,4} 
Low {3,4,5} 
Medium low {4,5,6} 
Medium {5,6,7} 
Medium high {6,7,8} 
High {7,8,9} 
Very high {8,9,10} 
Extremely high {9,10,10} 
 
Table 3. Euclidean Distance 
 
  Seftriaxone Ondansetron Irbesartan Glimepiride Omeprazole 
Seftriaxone 0 0,611 0,692 0,849 0,187 
Ondansetron 0,611 0 0,230 0,442 0,541 
Irbesartan 0,692 0,230 0 0,214 0,680 
Glimepiride 0,849 0,442 0,214 0 0,868 
Omeprazole 0,187 0,541 0,680 0,868 0 
 
 
 
Figure 4. Mapping Item 
 
 
Supply Risk 
Profit Impact 
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Figure 5. Conventional procurement system 
 
 Figure 5 shows that the supply chain of 
conventional procurement system of omeprazole 
starting from the manufacturer to Pedagang Besar 
Farmasi (PBF) Centre. PBF appointed by 
manufacturers to market their products.  
 Then the PBF will market the product to the next 
PBF Branch. PBF Branch offering products to 
hospitals through sales. Having agreed with the price 
offered, the hospital will buy the product. 
 Below is a table of selling price difference of 
each stakeholder obtained from interviews with 
relevant parties 
 
Table 4. Price Camparison between Stakeholders 
 
Factory PBF 
Rp. 
7.417/pcs 
Rp. 40.000/pcs 
 
The price offered by factory and PBF depending on 
the volume of purchases and discounts offered. 
Following the calculation of mark up disposable 
syringe 5cc : 
 
 
 
 
 
= 439,33% ≈ 493% 
 
The selling price at the PBF is Rp. 40.000 / pcs. 
Components of the cost of the e-catalog procurement 
system and the conventional procurement system the 
same such as profits, distribution costs, storage costs, 
fees of Human Resources (HR), and other costs 
(electricity, rent and others), the difference is the cost 
of promotion. In the e-catalog procurement system, 
there is no promotional costs. PBF do not need to 
submit offers to the hospital because the hospital 
directly select items with the desired specifications 
and price. 
 The 5cc disposable syringe supply chain e-
catalog procurement system is shown by the following 
picture : 
 
 
 
 
 
 
 
 
 
 
Figure 6. E-catalog system 
 
 Figure 6 shows e-catalog procurement system.  
supply chain starting from the factory or 
manufactures. Factories enter the price and 
specifications of the items into the e–catalog system. 
When hospitals purchase items through e–catalog, the 
factory will contact the appointed PBF to deliver the 
goods to the hospital. Hospitals accept the orders for 
goods and pay according to the price on the e -Catalog 
through distributors. 
The difference occurring in the purchase using e-
Catalog and conventional method is 10% in which the 
purchasing price through e-Catalog is lower than that 
through the conventional method. Calculation to 
determine the difference in prices is shown below: 
 
 
 
 
= 10% 
 
Conclusion  
According to the categorization using the Kraljic 
Portfolio Matrix, the medicine item omeprazole is in 
strategic item category so it is recommended to do a 
partnership with its supplier. The medicine item 
ondansetron and irbesartan are in leverage quadrant, 
the recommendation given is by building a partnership 
strategy with a competent supplier. Meanwhile, 
seftriaxone is in bottleneck strategy and glimepiride is 
in non-critical category.  
By using e-Catalog, medicine item omeprazole 
which is in strategic item is expected to move to 
leverage quadrant, where the item will have a high 
profit impact but low supply risk.  
The medicine supply chain begins with 
pharmacy factory, then it is distributed through central 
PBF and will be handled by PBF branches according 
to each region so it may arrive at the retailer, which in 
this case is hospitals. There is no difference between 
e-Catalog and conventional, it is just that the contract 
using e-Catalog is through pharmacy factory, while in 
the conventional system, the contract is through PBF. 
The increase of value from factory to hospital 
includes tax, profit, distribution cost, retention cost, 
human resource cost, and other costs (electricity, 
rental place, and others). Purchase through e-Catalog 
have a 10% less price than the price through 
conventional method. 
Factory 
 
PBF Branch Hospital 
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The plot of medicine supply chain cannot be 
shortened, because the distribution of medicine needs 
a complex handling in which medicine factories 
cannot do a direct distribution, instead having to do it 
through PBF. 
The procurement of medicine through e-Catalog 
is an example of e-Marketplace, in which in e-
Marketplace, there exists interaction between various 
companies in the cyberspace without it being limited 
by territory (geographical area) or time. Medicine e-
Catalog is the meeting place between various 
suppliers (pharmacy factories) with consumers to do 
sale and purchase transactions. 
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